CAR-T 治疗的疗效、安全性和成本效果 Efficacy, safety and cost-effectiveness of CAR-T therapy. PubMed 2026/02/18 发表Br J Clin PharmacolQ2 · IF 3(JCR 2025) 人群:儿童靶点:CD19技术:CAR-T多发性骨髓瘤胶质母细胞瘤骨肉瘤
利用旁分泌 SIRPγ 衍生的 CD47 阻断剂增强抗 EGFRvIII CAR-T 细胞治疗对胶质母细胞瘤的疗效 Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker. PubMed 2024/11/09 发表Nat CommunQ1 · IF 18.1(JCR 2025) 靶点:CD19靶点:EGFRvIII技术:CAR-T胶质母细胞瘤淋巴瘤地区:欧洲